Sanofi announced that it signed a deal with Roche for exclusive over-the-counter rights to Tamiflu to prevent and treat influenza in the U.S. The company will now be responsible for negotiating the switch to over-the counter (OTC) with the FDA, in addition to marketing, scientific engagement, and distribution of Tamiflu OTC in the United States, according to the press release. Read more here.